NCT05180721

Brief Summary

The purpose of the study is to develop and evaluate a multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 6, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

October 3, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

July 10, 2025

Completed
Last Updated

July 10, 2025

Status Verified

June 1, 2025

Enrollment Period

1.7 years

First QC Date

December 14, 2021

Results QC Date

May 28, 2025

Last Update Submit

June 21, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Usage of Portal

    Frequency. Mean portal login days/per month will be calculated using the EMR system

    Monthly for 6 months

  • Change in A1C Value

    The A1C value will be assessed via fingerprick point of care A1c kits.

    Baseline, 3 months and 6 months

Secondary Outcomes (4)

  • Summary of Self-Care in Diabetes Survey- Diet

    Baseline, 3 months, and 6 months

  • Diabetes Self-Efficacy

    Baseline, 3 months, 6 months

  • Health Care Climate Questionnaire

    Baseline, 3 months, 6 months

  • Problem Areas in Diabetes (PAID)

    Baseline, 3 and 6 months

Study Arms (1)

Use of patient portal for diabetes management

EXPERIMENTAL

A multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).

Behavioral: Use of patient portal for diabetes management

Interventions

A multi-level intervention aimed at increasing access and use of patient portals for diabetes management (MAP) in community health centers (CHCs).

Use of patient portal for diabetes management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Established patient of one of the partner CHCs
  • Age \> 18 years
  • Diagnosed with T2D \>6 months
  • Able to read in English or Spanish
  • Not using the patient portal
  • A1c \>7.5%

You may not qualify if:

  • Cognitive impairment (≥3 errors on the Six Item Screener for cognitive impairment in clinical research \[SIS\]) (Callahan et al. 2002) as they will have difficulty in completing the study requirements
  • Gestational diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Fair Haven Community Health Center

New Haven, Connecticut, 06510, United States

Location

Norwalk Community Health Center

Norwalk, Connecticut, 06854, United States

Location

Related Publications (2)

  • Wagner J, Akyirem S, Lipson J, Chen HN, Whittemore R. Evaluation of the implementation of a patient portal pilot intervention among people with type 2 diabetes at community health centers. Front Clin Diabetes Healthc. 2026 Jan 6;6:1689830. doi: 10.3389/fcdhc.2025.1689830. eCollection 2025.

  • Whittemore R, Jeon S, Akyirem S, Chen HNC, Lipson J, Minchala M, Wagner J. Multilevel Intervention to Increase Patient Portal Use in Adults With Type 2 Diabetes Who Access Health Care at Community Health Centers: Single Arm, Pre-Post Pilot Study. JMIR Form Res. 2025 Mar 25;9:e67293. doi: 10.2196/67293.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Robin Whittemore
Organization
Yale

Study Officials

  • Robin Whittemore, PhD, APRN

    Yale University

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2021

First Posted

January 6, 2022

Study Start

October 3, 2022

Primary Completion

July 2, 2024

Study Completion

July 2, 2024

Last Updated

July 10, 2025

Results First Posted

July 10, 2025

Record last verified: 2025-06

Locations